Prof Giovanni Stracquadanio

Giovanni is a Professor (Chair) of Engineering Biology, EPSRC fellow, Deputy Director of the Centre for Engineering Biology, and co-director of the Edinburgh Genome Foundry (EGF) at the University of Edinburgh. 

His group is interested in unveiling the genetics and molecular mechanisms leading to diseases to design next-generation therapeutics using two of the most disruptive technologies available: engineering biology and artificial intelligence.

His group is currently focused on developing next-generation enzyme replacement therapies for Lysosomal Storage Diseases (LSD), to deliver more effective and sustainable treatments to Fabry disease patients.

Giovanni is also the co-founder and CEO of ZYTHERA, an early-stage start-up developing next-generation enzyme replacement therapies for lysosomal storage diseases. 

AI protein engineering to design effective ERTs

Presentation overview to follow